Kynmobi (apomorphine hydrochloride)

pCPA File Number: 21410
Negotiation Status:
Concluded with an LOI
Indication(s):
Parkinson's disease
Sponsor/Manufacturer:
Sunovion Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0650-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: